Our Cases

Compass Lexecon has been involved in many of the largest and most complex antitrust litigation and financial market cases over the past 30 years.

Find a Case

Sorry, your search didn't return any results.

08/19/19

In December 2018, GlaxoSmithKline plc (GSK) and Pfizer Inc. agreed to combine their consumer healthcare businesses through a multi-billion dollar transaction. GSK markets common over the counter health care products such as Excedrin, TUMs, Prevacid, and Triaminic, while Pfizer markets...

07/11/19

On 27 June 2019, the European Commission unconditionally approved the acquisition of Red Hat by IBM at Phase I. The Commission’s clearance decision followed unconditional approvals by the U.S. Department of Justice and several other national competition authorities. The $34...

01/17/19

In January 2019, Solenis and BASF completed the creation of a joint venture combining their global paper and water chemicals businesses, with a pro forma sales value of approximately $3 billion. Compass Lexecon advised the parties and their legal advisors...

12/23/18

In December 2018, the European Commission approved the acquisition by which KME acquired MKM after a Phase II investigation. Both parties are suppliers of copper and copper alloy products. Compass Lexecon provided economic advice to MKM, advising mainly on the...

11/18/18

In November 2018, the UK Competition & Markets Authority ("CMA") cleared the £26 million acquisition by AC Nielsen of the advertising intelligence division (AdIntel) of Ebiquity plc, after a Phase II investigation. Both companies gather, collate and analyze information on...

03/16/18

On March 16, 2018, Suzano Papel e Celulose S.A. (“Suzano”) announced its plan to acquire Fibria Celulose S.A. (“Fibria”). The two companies are both leading Brazilian suppliers of eucalyptus pulp in the Americas, Europe, and Asia. Compass Lexecon was retained...

07/17/15

In June 2015, the Competition Appeal Court of South Africa (the CAC) absolved Sasol Chemical Industries of the excessive pricing complaint against it. In doing so, the CAC overturned the decision of the Competition Tribunal. Compass Lexecon initially advised Sasol...

01/21/15

In January 2015, the European Commission cleared the $13 billion (£9.2 billion) transaction between GlaxoSmithKline (GSK) and Novartis, subject to conditions, after a Phase I investigation. The transaction involved (a) the transfer of Novartis' human vaccines to GSK; (b) a...

05/05/11

On May 5, 2011, the European Commission (EC) cleared without conditions the proposed combination of Citrovita (Votorantim group) and Citrosuco (Fisher group) to form the world’s largest wholesale supplier of orange juice. Unconditional clearance was awarded after an in-depth, Phase...